Researchers examine how precision medicine may prevent suicide

A team of researchers at Indianapolis-based Indiana University School of Medicine have found a link between blood biomarkers and suicide risk, according to a study published in Molecular Psychiatry.

The research team, led by Alexander B. Niculescu III, MD, PhD, investigated blood gene expression biomarkers for suicide using a multistep approach, beginning with blood samples from 66 people diagnosed with psychiatric disorders. They tested those blood samples against biomarkers identified from blood samples of 45 people who had committed suicide.

Based on their findings, the researchers subsequently tested samples against another group of individuals to determine how well they could predict if an individual would report suicidal thoughts. They determined levels of certain RNA molecules changed in a person's blood as they experienced suicidal thoughts.

"We hope that our risk assessment tools may become self-canceling predictions … as they can lead to precision prevention with early targeted interventions: biological, psychological and social," the study authors conclude. "Given that one person dies from suicide every 40 seconds worldwide, the importance and urgency of efforts such as ours cannot be overstated."

Click here to read the full paper.

More articles on population health:

Cancer Treatment Centers of America expands efforts with Foundation Medicine in precision medicine project

How video games could help treat mental disorders

California: Pathologists must report cancer diagnoses to electronic registry by 2019

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars